In patients with non-alcoholic fatty liver disease (NAFLD), resveratrol significantly reduces the levels of glucose, cholesterol, and liver enzymes ALT and aspartate aminotransferase (78). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.